ETX001

TMEM16A potentiator

Phase of research

Pre-clinical

How it helps

Mucociliary Clearance

General information

ETX001 is an experimental substance used in studies and not yet available as a human pharmaceutical. It potentiates TMEM16, a CFTR chloride channel in epithelial cells. In relation to cystic fibrosis, our AIM tool found the data that ETX001 can help enhance mucus clearance independent of CFTR function.

Synonyms

N/A

Marketed as

N/A

Dietary sources

N/A

Structure image not available

Drug-Mutation Relation

results for R352Q / G542X

See all data on ETX001

Treats

Mutation	Link	Tested on	Impact factor	Notes
General effect	TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.	sheep	16.49

Does not treat

Mutation	Link	Tested on	Impact factor	Notes